Volume 11 Issue 1
Jan.  2020
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(1): 66-71, 103
Li Lijuan, Lu Pinglan, Zhou Mi, et al. Enhanced recovery after surgery improves clinical outcomes of liver transplant recipients[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 66-71, 103. doi: 10.3969/j.issn.1674-7445.2020.01.010
Citation: Li Lijuan, Lu Pinglan, Zhou Mi, et al. Enhanced recovery after surgery improves clinical outcomes of liver transplant recipients[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 66-71, 103. doi: 10.3969/j.issn.1674-7445.2020.01.010
shu

Enhanced recovery after surgery improves clinical outcomes of liver transplant recipients

doi: 10.3969/j.issn.1674-7445.2020.01.010

  • Surgical Intensive Care Unit, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

More Information
  • Corresponding author: Lyu Haijin, Email:lvhaijin@mail.sysu.edu.cn
  • Received Date: 2019-10-05
    Available Online: 2021-01-19
  • Publish Date: 2020-01-15
    Abstract
  •   Objective  To investigate the rationality and efficacy of enhanced recovery after surgery (ERAS) in liver transplant recipients.  Methods  Clinical data of 465 liver transplant recipients were retrospectively analyzed. All recipients were divided into the ERAS group (n=163) and control group (n=302) according to whether they received ERAS. The severity of disease in the ERAS group was worse than that in the control group. Operation situations including the operation time, anhepatic phase and intraoperative blood transfusion volume of the liver transplant recipients were observed and recorded. Postoperative recovery conditions including the length of intensive care unit (ICU) stay, total length of hospital stay, total ventilator removal time at postoperative 28 d and postoperative re-intubation rate were recorded. The survival rates at 90 d, 180 d and 1 year after liver transplantation were calculated. The influencing factors of survival rate of liver transplant recipients were analyzed.  Results  The anhepatic phase in the ERAS group was 45 (39, 53) min, significantly longer than 40 (32, 48) min in the control group (P < 0.05). The volume of erythrocyte infusion in the ERAS group was 10 (7, 13) U, significantly less than 18 (10, 28) U in the control group (P < 0.05). The length of postoperative ICU stay and total length of hospital stay in the ERAS group were 135 (84, 212) h and 24 (18, 33) d, significantly shorter than 154 (103, 253) h and 34 (20, 50) d in the control group (both P < 0.05). Total ventilator removal time at postoperative 28 d was 26 (25, 27) d, significantly longer than 26 (23, 27) d in the control group (P < 0.05). The postoperative re-intubation rate in the ERAS group was 11.0%, significantly lower than 20.8% in the control group (P < 0.05). The 90 d, 180 d and 1-year survival rates in the ERAS group were 92.8%, which were significantly higher than 81.1%, 78.1% and 75.7% in the control group (all P < 0.05). ERAS and operation time were the independent influencing factors of survival rate of liver transplant recipients (both P < 0.05).  Conclusions  ERAS after liver transplantation can improve the survival rate of recipient, shorten the length of hospital stay, reduce the re-intubation rate and accelerate the rehabilitation after liver transplantation.

     

    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    杨磊, 代世韬, 姚尚龙.肝移植麻醉精细化管理——科学与艺术的体现[J].器官移植, 2018, 9(6):414-416. DOI: 10.3969/j.issn.1674-7445.2018.06.003.

    YANG L, DAI ST, YAO SL. Precision management of liver transplantation anesthesia——the reflect of science and art [J]. Organ Transplant, 2018, 9(6):414-416. DOI: 10.3969/j.issn.1674-7445.2018.06.003.
    [2]
    BRUSTIA R, MONSEL A, CONTI F, et al. Enhanced recovery in liver transplantation: a feasibility study[J]. World J Surg, 2019, 43(1):230-241. DOI: 10.1007/s00268-018-4747-y.
    [3]
    LI M, ZHANG W, JIANG L, et al. Fast track for open hepatectomy: a systemic review and Meta-analysis[J]. Int J Surg, 2016, 36(Pt A):81-89. DOI: 10.1016/j.ijsu.2016.10.019.
    [4]
    MEDBERY RL, FERNANDEZ FG, KHULLAR OV. ERAS and patient reported outcomes in thoracic surgery: a review of current data[J]. J Thorac Dis, 2019, 11(Suppl 7): S976-S986. DOI: 10.21037/jtd.2019.04.08.
    [5]
    CAO Y, GU HY, HUANG ZD, et al. Impact of enhanced recovery after surgery on postoperative recovery for pancreaticoduodenectomy: pooled analysis of observational study[J]. Front Oncol, 2019, 9:687. DOI: 10.3389/fonc.2019.00687.
    [6]
    GRECO M, CAPRETTI G, BERETTA L, et al. Enhanced recovery program in colorectal surgery: a Meta-analysis of randomized controlled trials[J]. World J Surg, 2014, 38(6):1531-1541. DOI: 10.1007/s00268-013-2416-8.
    [7]
    LJUNGQVIST O, SCOTT M, FEARON KC. Enhanced recovery after surgery: a review[J]. JAMA Surg, 2017, 152(3):292-298. DOI: 10.1001/jamasurg.2016.4952.
    [8]
    MELLOUL E, HÜBNER M, SCOTT M, et al. Guidelines for perioperative care for liver surgery: enhanced recovery after surgery (ERAS) society recommendations[J]. World J Surg, 2016, 40(10):2425-2440. DOI: 10.1007/s00268-016-3700-1.
    [9]
    NEWMAN KL, JOHNSON KM, CORNIA PB, et al. Perioperative evaluation and management of patients with cirrhosis: risk assessment, surgical outcomes, and future directions[J]. Clin Gastroenterol Hepatol, 2019, DOI: 10.1016/j.cgh.2019.07.051[Epubahead of print].
    [10]
    NI X, JIA D, GUO Y, et al. The efficacy and safety of enhanced recovery after surgery (ERAS) program in laparoscopic digestive system surgery: a Meta-analysis of randomized controlled trials[J]. Int J Surg, 2019, 69:108-115. DOI: 10.1016/j.ijsu.2019.07.034.
    [11]
    PUPPO MORENO AM, ABELLA ALVAREZ A, MORALES CONDE S, et al. The intensive care unit in the postoperative period of major abdominal surgery[J]. Med Intensiva, 2019, 43(9):569-577. DOI: 10.1016/j.medin. 2019.05.007.
    [12]
    DIETZ N, SHARMA M, ADAMS S, et al. Enhanced recovery after surgery (ERAS) for spine surgery: a systematic review[J]. World Neurosurg, 2019, 130:415-426. DOI: 10.1016/j.wneu.2019.06.181.
    [13]
    乔华, 李钰, 李琳.肝移植术后患者疲劳状况与依从性和生命质量的相关性研究[J].中国实用护理杂志, 2017, 33(33):2585-2589.DOI:10.3760/cma.j.issn.1672- 7088.2017.33.006.

    QIAO H, LI Y, LI L. The relationship between status of fatigue and compliance, quality of life in patients after liver transplantation[J]. Chin J Pract Nurs, 2017, 33(33):2585-2589. DOI: 10.3760/cma.j.issn.1672-7088.2017.33.006.
    [14]
    ABY ES, SAAB S. Frailty, sarcopenia, and malnutrition in cirrhotic patients[J]. Clin Liver Dis, 2019, 23(4):589-605. DOI: 10.1016/j.cld.2019.06.001.
    [15]
    CZIGANY Z, KRAMP W, BEDNARSCH J, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation[J]. Am J Transplant, 2019, DOI: 10.1111/ajt.15577[Epubahead of print].
    [16]
    WILLIAMS FR, BERZIGOTTI A, LORD JM, et al. Review article: impact of exercise on physical frailty in patients with chronic liver disease[J]. Aliment Pharmacol Ther, 2019, 50(9):988-1000. DOI: 10.1111/apt.15491.
    [17]
    DONG V, SUN K, GOTTFRIED M, et al. Significant lung injury and its prognostic significance in acute liver failure: a cohort analysis[J]. Liver Int, 2019, DOI: 10.1111/liv.14268[Epubahead of print].
    [18]
    KING AB, KENSINGER CD, SHI Y, et al. Intensive care unit enhanced recovery pathway for patients undergoing orthotopic liver transplants recipients: a prospective, observational study[J]. Anesth Analg, 2018, 126(5):1495-1503. DOI: 10.1213/ANE.0000000000002851.
    [19]
    HOPP AE, DIRKS M, PETRUSCH C, et al. Hepatic encephalopathy is reversible in the long term after liver transplantation[J]. Liver Transpl, 2019, 25(11):1661-1672. DOI: 10.1002/lt.25626.
    [20]
    STRAVITZ RT, LEE WM. Acute liver failure[J]. Lancet, 2019, 394(10201):869-881.DOI: 10.1016/S0140-6736(19) 31894-X.
    [21]
    KWON HM, MOON YJ, JUNG KW, et al. Appraisal of cardiac ejection fraction with liver disease severity: implication in post-liver transplantation mortality[J]. Hepatology, 2019, DOI: 10.1002/hep.30913[Epubahead of print].
    [22]
    CARRIER FM, CHASSé M, WANG HT, et al. Restrictive fluid management strategies and outcomes in liver transplantation: a systematic review[J]. Can J Anaesth, 2020, 67(1):109-127. DOI: 10.1007/s12630-019-01480-y.
    [23]
    中国医师协会器官移植分会移植免疫学组, 中华医学会外科学分会手术学组, 广东省医师协会器官移植医师分会.加速康复外科优化重型肝炎肝移植围手术期管理临床实践的专家共识[J].临床肝胆病杂志, 2017, 33(9):1646-1654.DOI: 10.3969/j.issn.1001-5256.2017.09.05.

    Transplantation Immunology Group of Branch of Organ Transplant Physician of Chinese Medical Doctor Association, Surgical Group of Branch of Surgery of Chinese Medical Association, Branch of Organ Transplant Physician of Guangdong Medical Doctor Association. Expert consensus on the optimization of perioperative management of liver transplantation for severe hepatitis by enhanced recovery after surgery[J]. J Clin Hepatol, 2017, 33(9):1646-1654. DOI: 10.3969/j.issn.1001-5256.2017.09.05.
    [24]
    KASRAIAN L, NIKEGHBALIAN S, KARIMI MH. Blood product transfusion in liver transplantation and its impact on short-term survival[J]. Int J Organ Transplant Med, 2018, 9(3):105-111. http://cn.bing.com/academic/profile?id=61188974784471d79ad92e3701d910ce&encoded=0&v=paper_preview&mkt=zh-cn
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (185) PDF downloads(25) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return